Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maximilian Lebmeier"'
Autor:
Jonathan Dando, Maximilian Lebmeier
Publikováno v:
Journal of Innovation and Entrepreneurship, Vol 9, Iss 1, Pp 1-28 (2020)
Abstract All stakeholders involved in the development, licencing, and market access of health care technologies use stage-specific valuation matched that integrates risks and outcomes to inform their decision making. A stage-specific valuation method
Externí odkaz:
https://doaj.org/article/9792516c6ed945ae8bf10834f7ee5fab
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145524 (2015)
BACKGROUND:Evaluating long-term prognosis is important for physicians, patients and payers. This study reports the results of a model developed to predict long-term survival for UK patients receiving second-line ipilimumab. METHODS:MDX010-20 trial da
Externí odkaz:
https://doaj.org/article/683c15a476f94d2cb009ee797f9096c9
Publikováno v:
AARMS: Academic & Applied Research in Military & Public Management Science; 2022, Vol. 21 Issue 2, p99-111, 13p
Autor:
Dando, Jonathan1 (AUTHOR) dandojonathan@hotmail.com, Lebmeier, Maximilian2 (AUTHOR)
Publikováno v:
Journal of Innovation & Entrepreneurship. 1/9/2020, Vol. 9 Issue 1, p1-28. 28p.
Autor:
Hatswell, Anthony J.1 ahatswell@bresmed.co.uk, Pennington, Becky1 bpennington@bresmed.co.uk, Pericleous, Louisa2 louisa.pericleous@gmail.com, Rowen, Donna3 d.rowen@sheffield.ac.uk, Lebmeier, Maximilian2 maximilian.lebmeier@bms.com, Lee, Dawn1 dlee@bresmed.co.uk
Publikováno v:
Health & Quality of Life Outcomes. 2014, Vol. 12 Issue 1, p1-17. 17p.
Publikováno v:
Transplant International; Nov2013 Supplement 2, Vol. 26, p1-184, 12p
Publikováno v:
Rheumatology; Apr2009, Vol. 48 Issue suppl_1, pi58-i58, 1p